EUVIMEDEUVIMED entdecken
Open Access

Fundamental changes in regulation to improve access to biosimilars

Hye-Na Kang, Ivana Knezevic, Meenu Wadhwa, Eun Kyung Kim

Bulletin of the World Health Organization · 01.07.2026 · 104 (7) · 517-521

DOI: 10.2471/blt.25.294908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of the World Health Organization, online erschienen am 01.07.2026. Verfasst von Hye-Na Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medicines and Health Products Policies and Standards Department, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Medicines and Health Products Policies and Standards Department, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
  • Biotherapeutics and Advanced Therapies, R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, England.

Förderung

  • World Health Organization

Zitieren

APA

Kang, H. N., Knezevic, I., Wadhwa, M., & Kim, E. K. (2026). Fundamental changes in regulation to improve access to biosimilars. Bulletin of the World Health Organization, 104(7), 517-521. https://doi.org/10.2471/blt.25.294908

Vancouver

Kang HN, Knezevic I, Wadhwa M, Kim EK. Fundamental changes in regulation to improve access to biosimilars. Bulletin of the World Health Organization. 2026;104(7):517-521. doi:10.2471/blt.25.294908

BibTeX
@article{Kang2026,
  author = {Kang, Hye-Na and Knezevic, Ivana and Wadhwa, Meenu and Kim, Eun Kyung},
  title = {Fundamental changes in regulation to improve access to biosimilars},
  journal = {Bulletin of the World Health Organization},
  year = {2026},
  volume = {104},
  number = {7},
  pages = {517--521},
  doi = {10.2471/blt.25.294908}
}
Kostenlos starten →